Blue Charm Adherence

Founded in 2020 in Canada, Blue Charm Adherence Inc. focuses on enhancing health management for patients with chronic diseases through tailored digital programs.00 mn. The core product offerings include programs tailored for various conditions such as Asthma, Multiple Sclerosis, Chronic Obstructive Pulmonary Disease (COPD), Inflammatory Bowel Disease (IBD), Severe Asthma, Obesity, and Type 2 Diabetes. Each program allows eligible participants to share their experiences through surveys and contribute valuable health data while earning financial incentives up to USD 120 e-transfer for healthcare services and expenses. These services are primarily targeted at individuals diagnosed with specific conditions who have valid prescriptions, facilitating improved health outcomes through active engagement in their treatment journeys.Blue Charm's revenue model is built on facilitating transactions that reward patient engagement in health management. The company's structure revolves around direct-to-consumer interactions, where patients enroll in programs aligned with their health conditions and participate in surveys that yield insights for ongoing health research. Participants are incentivized with financial compensation for providing feedback, thereby creating a sustainable ecosystem where patients benefit from their involvement. Each program has defined eligibility criteria and compensation levels, which may include up to USD 120 or USD 100 e-transfer based on the specific health condition being addressed.In September 2025, Blue Charm Adherence Inc. The company is focused on expanding its digital health programs into new geographic markets, though specific regions have yet to be disclosed. Upcoming product launches are also in the pipeline to enhance the offerings tailored for patients with chronic diseases.

1. Seed

   Sep 9, 2025

   Amount

   $4M

   Investors

   Locked